Copanlisib Chinese PK Study

Clinical trial NCT03498430 · COMPLETED

Trial details

NCT number: NCT03498430
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2018-04-27
Primary completion: 2019-08-06
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.